阿卡迪亞製藥公司
US ˙ NasdaqGS ˙ US0042251084

SecurityACAD / ACADIA Pharmaceuticals Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership213,263 shares
Latest Disclosed Value $ 4,600,082
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series reports 4.57% increase in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 213,263 shares of ACADIA Pharmaceuticals Inc. (US:ACAD) valued at $4,600,083 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 203,943 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of 4.57% during the quarter. The current value of the position is $4,597,950 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP ACADIA Pharmaceuticals EC US0042251084 213,263 9,320 4.57 4,600 35.81 0.1033
2025-05-28 2025-03-31 NP ACADIA Pharmaceuticals EC US0042251084 203,943 2,165 1.07 3,387 -8.51 0.0813
2025-02-25 2024-12-31 NP ACADIA Pharmaceuticals EC US0042251084 201,778 -35,248 -14.87 3,703 1.56 0.0809
2024-11-26 2024-09-30 NP ACADIA Pharmaceuticals EC US0042251084 237,026 5,646 2.44 3,645 -3.03 0.0689
2024-08-26 2024-06-30 NP ACADIA Pharmaceuticals EC US0042251084 231,380 17,437 8.15 3,760 -4.96 0.0766
2024-05-28 2024-03-31 NP ACADIA Pharmaceuticals EC US0042251084 213,943 -6,708 -3.04 3,956 -42.75 0.0825
2024-02-26 2023-12-31 NP ACADIA Pharmaceuticals EC US0042251084 220,651 15,161 7.38 6,909 61.33 0.1475
2023-11-28 2023-09-30 NP ACADIA Pharmaceuticals EC US0042251084 205,490 -4,523 -2.15 4,282 -14.85 0.1117
2023-08-25 2023-06-30 NP ACADIA Pharmaceuticals EC US0042251084 210,013 18,611 9.72 5,030 39.62 0.1193
2023-05-26 2023-03-31 NP ACADIA Pharmaceuticals EC US0042251084 191,402 1,718 0.91 3,602 19.31 0.0959
2023-02-24 2022-12-31 NP ACADIA Pharmaceuticals EC US0042251084 189,684 -3,640 -1.88 3,020 -4.52 0.0831
2022-11-25 2022-09-30 NP ACADIA Pharmaceuticals EC US0042251084 193,324 0 0.00 3,163 16.12 0.0906
2022-08-25 2022-06-30 NP ACADIA Pharmaceuticals EC US0042251084 193,324 7,300 3.92 2,724 -39.56 0.0752
2022-05-26 2022-03-31 NP ACADIA Pharmaceuticals EC US0042251084 186,024 3,245 1.78 4,506 5.60 0.1050
2022-02-25 2021-12-31 NP ACADIA Pharmaceuticals EC US0042251084 182,779 -7,550 -3.97 4,266 34.96 0.0925
2021-11-24 2021-09-30 NP ACADIA Pharmaceuticals EC US0042251084 190,329 9,988 5.54 3,161 -28.13 0.0696
2021-08-26 2021-06-30 NP ACADIA Pharmaceuticals EC US0042251084 180,341 -2,962 -1.62 4,399 -43.21 0.0944
2020-06-01 2020-03-31 NP ACADIA Pharmaceuticals EC US0042251084 183,303 7,791 4.44 7,745 3.14 0.3166
2020-02-27 2019-12-31 NP ACADIA Pharmaceuticals EC 004225108 175,512 14,250 8.84 7,508 29.38 0.2258
2019-11-27 2019-09-30 NP ACADIA Pharmaceuticals EC US0042251084 161,262 161,262 5,804 0.1918
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.